212 related articles for article (PubMed ID: 20838345)
41. Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications.
Jerrell JM; McIntyre RS
Hum Psychopharmacol; 2007 Aug; 22(6):361-4. PubMed ID: 17562519
[TBL] [Abstract][Full Text] [Related]
42. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
43. [Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview].
Scheepers-Hoeks AM; Wessels-Basten SJ; Scherders MJ; Bravenboer B; Loonen AJ; Kleppe RT; Grouls RJ
Tijdschr Psychiatr; 2008; 50(10):645-54. PubMed ID: 18951343
[TBL] [Abstract][Full Text] [Related]
44. Risk of serious cardiac events in older adults using antipsychotic agents.
Mehta S; Chen H; Johnson M; Aparasu RR
Am J Geriatr Pharmacother; 2011 Apr; 9(2):120-32. PubMed ID: 21565711
[TBL] [Abstract][Full Text] [Related]
45. Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics.
Bell RC; Farmer S; Ries R; Srebnik D
Psychiatr Serv; 2009 Dec; 60(12):1686-9. PubMed ID: 19952163
[TBL] [Abstract][Full Text] [Related]
46. Antipsychotic treatment and mortality in schizophrenia.
Torniainen M; Mittendorfer-Rutz E; Tanskanen A; Björkenstam C; Suvisaari J; Alexanderson K; Tiihonen J
Schizophr Bull; 2015 May; 41(3):656-63. PubMed ID: 25422511
[TBL] [Abstract][Full Text] [Related]
47. Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.
Ronaldson KJ
CNS Drugs; 2017 Sep; 31(9):777-795. PubMed ID: 28808933
[TBL] [Abstract][Full Text] [Related]
48. Comparing safety and tolerability of antipsychotic treatment.
Newcomer JW; Lieberman JA
J Clin Psychiatry; 2007 Mar; 68(3):e07. PubMed ID: 17388701
[TBL] [Abstract][Full Text] [Related]
49. Follow-up interventions in persons with schizophrenia and metabolic syndrome.
Kølbæk P; Schiöth E; Aagaard J; Munk-Jørgensen P
Aust N Z J Psychiatry; 2014 Nov; 48(11):1059-60. PubMed ID: 25277542
[No Abstract] [Full Text] [Related]
50. Mortality in patients with schizophrenia.
De Hert M; Peuskens J; van Winkel R
Lancet; 2009 Nov; 374(9701):1591; author reply 1592-3. PubMed ID: 19897118
[No Abstract] [Full Text] [Related]
51. Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis.
Scigliano G; Ronchetti G
CNS Drugs; 2013 Apr; 27(4):249-57. PubMed ID: 23533011
[TBL] [Abstract][Full Text] [Related]
52. Care map. 3: Atypical antipsychotics. Hyperlipidaemia/cardiovascular disease.
Houltram B; Scanlan M
Nurs Stand; 2004 Jun 9-15; 18(39):43-4. PubMed ID: 15214120
[No Abstract] [Full Text] [Related]
53. Cardiovascular effects of psychotic illnesses and antipsychotic therapy.
Howell S; Yarovova E; Khwanda A; Rosen SD
Heart; 2019 Dec; 105(24):1852-1859. PubMed ID: 31439658
[TBL] [Abstract][Full Text] [Related]
54. [Brazilian Consensus on second-generation antipsychotics and metabolic disorders].
Elkis H; Gama C; Suplicy H; Tambascia M; Bressan R; Lyra R; Cavalcante S; Minicucci W
Braz J Psychiatry; 2008 Mar; 30(1):77-85. PubMed ID: 18373022
[TBL] [Abstract][Full Text] [Related]
55. Schizophrenia and the metabolic syndrome.
Harv Ment Health Lett; 2006 Oct; 23(4):7. PubMed ID: 17183742
[No Abstract] [Full Text] [Related]
56. Mortality in schizophrenia.
Hasnain M; Vieweg WV; Mezuk B
J Psychopharmacol; 2011 Jun; 25(6):846-7. PubMed ID: 21421641
[No Abstract] [Full Text] [Related]
57. [Why do schizophrenic patients die sooner?].
Stiefelhagen P
MMW Fortschr Med; 2009 Jun; 151(24):17. PubMed ID: 19645193
[No Abstract] [Full Text] [Related]
58. Development of a health screening clinic.
Millar HL
Eur Psychiatry; 2010 Jun; 25 Suppl 2():S29-33. PubMed ID: 20620883
[TBL] [Abstract][Full Text] [Related]
59. Identifying metabolic risks with antipsychotics and monitoring and management strategies.
Newcomer JW; Sernyak MJ
J Clin Psychiatry; 2007 Jul; 68(7):e17. PubMed ID: 17685728
[TBL] [Abstract][Full Text] [Related]
60. Treating the mind and body in schizophrenia: risks and prevention.
Meyer JM
CNS Spectr; 2004 Oct; 9(10 Suppl 11):25-33. PubMed ID: 15475874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
